Key points are not available for this paper at this time.
Design
Editorial
Lipoprotein(a) is an independent risk factor for acute myocardial infarction, with levels primarily controlled by genetics and varying across populations.
Lipoprotein(a), or Lp(a), refers to lipoprotein particles composed of disulfide-linked apolipoprotein(a) and apolipoprotein B-100 around a cholesterol-rich lipid core. Since Berg's¹initial discovery in 1963 of Lp(a) as distinct from low-density lipoprotein, many studies (most of them retrospective and cross-sectional in nature) have demonstrated an association of atherosclerotic cardiovascular disease with high blood Lp(a) levels.²⁻⁴The Lp(a) level, which remains relatively constant throughout life, has been suggested to be a strong, independent risk factor for acute myocardial infarction (MI), particularly in younger individuals⁵or those without other predisposing risk factors. Population studies have revealed a skewed distribution of Lp(a) levels, particularly in white and Asian populations, while black populations tend to have a more normal distribution,⁶with higher mean levels, yet without a substantial increase in cardiovascular risk. Genetic analyses have revealed that Lp(a) levels are primarily controlled by a series of autosomal alleles at a
No takes yet. Share an insight, caveat, or question.
Elliot S. Barnathan (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: